WASHINGTON (MedPage Today) — The FDA has issued an update to its class I recall of a pole-mounted infusion pump — recommending that users double-check and tug the pump’s door latch to make sure the door is securely closed to prevent the free flow of therapy.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The House of Representatives has passed legislation temporarily halting the 23% cut in physician payments under Medicare scheduled to take effect on Dec. 1.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — FDA reviewers are questioning the benefits of two 5-alpha reductase inhibitors — dutasteride (Avodart) and finasteride (Proscar) — to prevent prostate cancer, in advance of a vote expected later this week by outside advisers on whether to expand the indication for dutasteride.
No Comments »
Filed under: General Health News
(MedPage Today) — Trying to be too clean may backfire for young people’s health, according to a study that suggests chemicals from antibacterial soaps and plastics depress the immune system and cause allergies.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — More than 25,000 physicians working in the federal government will see no raises before 2013, if a two-year pay freeze for all civilian federal employees proposed by President Obama is enacted.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — Makers of a cochlear implant device have issued a voluntary recall of the device due to malfunctions that may cause severe pain and shocking sensations within a few days of activation.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The FDA has issued an update to its class I recall of a pole-mounted infusion pump — recommending that users double-check and tug the pump’s door latch to make sure the door is securely closed to prevent the free flow of therapy.
No Comments »
Filed under: Pharmacy News
WASHINGTON (MedPage Today) — Makers of a cochlear implant device have issued a voluntary recall of the device due to malfunctions that may cause severe pain and shocking sensations within a few days of activation.
No Comments »
Filed under: Pharmacy News
Neuraltus Pharmaceuticals, a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet medical needs, primarily for the treatment of neurodegenerative diseases, announced today top-line results from the Company’s Phase 1 clinical study of NP001 for the treatment of Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig’s disease).
No Comments »
Filed under: Pharmacy News
Intellikine, a leader in the development of small molecule drugs targeting the PI3K/mTOR pathway, and the Multiple Myeloma Research Consortium (MMRC) today announced the initiation of a phase I trial of INK128, a novel, orally-available small molecule kinase inhibitor of the TORC1 and TORC2 complexes, in patients with multiple myeloma.
No Comments »
Filed under: Pharmacy News
